Optimizing levodopa pharmacokinetics in Parkinson's disease: the role of COMT inhibitor

被引:4
作者
Stocchi, F [1 ]
Vacca, L
Grassini, P
Battaglia, G
Onofrj, M
Valente, M
Ruggieri, S
机构
[1] IRRCS Neuromed, Pozzilli, IS, Italy
[2] Univ Roma La Sapienza, Dept Neurosci, Rome, Italy
[3] Univ G DAnnunzio, Dept Neurooncol, Chieti, Italy
关键词
D O I
10.1007/s10072-003-0138-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:217 / 218
页数:2
相关论文
共 21 条
[1]   Levodopa: why the controversy? [J].
Agid, Y ;
Olanow, CW ;
Mizuno, Y .
LANCET, 2002, 360 (9332) :575-575
[2]  
BLANCHET PJ, 1995, J PHARMACOL EXP THER, V272, P854
[3]  
CHASE TN, 1989, NEUROLOGY, V39, P7
[4]   Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease [J].
Colzi, A ;
Turner, K ;
Lees, AJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (05) :573-576
[5]   DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY OF DUODENAL INFUSION OF LEVODOPA CARBIDOPA IN PARKINSONS-DISEASE PATIENTS WITH ON-OFF FLUCTUATIONS [J].
KURTH, MC ;
TETRUD, JW ;
TANNER, CM ;
IRWIN, I ;
STEBBINS, GT ;
GOETZ, CG ;
LANGSTON, JW .
NEUROLOGY, 1993, 43 (09) :1698-1703
[6]   PARKINSONS-DISEASE [J].
MARSDEN, CD .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (06) :672-681
[7]  
MARSDEN CD, 1977, LANCET, V1, P345
[8]   Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D-2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy [J].
Morissette, M ;
Goulet, M ;
Soghomonian, JJ ;
Blanchet, PJ ;
Calon, F ;
Bedard, PJ ;
DiPaolo, T .
MOLECULAR BRAIN RESEARCH, 1997, 49 (1-2) :55-62
[9]   Pathophysiology of the basal ganglia in Parkinson's disease [J].
Obeso, JA ;
Rodríguez-Oroz, MC ;
Rodríguez, M ;
Lanciego, JL ;
Artieda, J ;
Gonzalo, N ;
Olanow, CW .
TRENDS IN NEUROSCIENCES, 2000, 23 (10) :S8-S19
[10]  
Olanow CW, 2000, ANN NEUROL, V47, pS167